Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Neurobiology of Disease|September 9, 2019
Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer's diseaseAderemi Caleb Aladeokin, Tomoko Akiyama, Ayuko Kimura, et al.Annals of Surgical Oncology|July 19, 2012
Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancerYukihiko Hiroshima, Fumio Nakamura, Hiroshi Miyamoto, et al.Frontiers in Neurology|October 14, 2022
Phosphorylated CRMP1, axon guidance protein, is a component of spheroids and is involved in axonal pathology in amyotrophic lateral sclerosisYuko Kawamoto, Mikiko Tada, Tetsuya Asano, et al.Journal of Pharmacological Sciences|January 22, 2022
Right ventricular overloading is attenuated in monocrotaline-induced pulmonary hypertension model rats with a disrupted Gpr143 gene, the gene that encodes the 3,4-l-dihydroxyphenyalanine (l-DOPA) receptorMasayuki Nakano, Motokazu Koga, Tatsuo Hashimoto, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 18, 2011
A seven-transmembrane receptor that mediates avoidance response to dihydrocaffeic acid, a water-soluble repellent in Caenorhabditis elegansReina Aoki, Tatsurou Yagami, Hiroyuki Sasakura, et al.JCI Insight|September 22, 2017
L-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptorDaiki Masukawa, Motokazu Koga, Anna Sezaki, et al.Elife|December 13, 2022
Monoallelic CRMP1 gene variants cause neurodevelopmental disorderEthiraj Ravindran, Nobuto Arashiki, Lena-Luise Becker, et al.Eneuro|May 6, 2022
Inhibition of Crmp1 Phosphorylation at Ser522 Ameliorates Motor Function and Neuronal Pathology in Amyotrophic Lateral Sclerosis Model MiceTetsuya Asano, Haruko Nakamura, Yuko Kawamoto, et al.Cancer Science|August 5, 2011
Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancerShingo Kato, Kensuke Kubota, Takeshi Shimamura, et al.Proceedings of the National Academy of Sciences of the United States of America|July 31, 2021
Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophreniaMunetaka Nomoto, Glenn T Konopaske, Naoya Yamashita, et al.Pageof 9